Indications: Fliban 100 (Flibanserin) is a medication primarily used in the treatment of hypoactive sexual desire disorder (HSDD) in premenopausal women. HSDD is characterized by a persistent lack of sexual desire or interest in sexual activity, leading to distress or interpersonal difficulties. Flibanserin is the first medication approved by the FDA specifically for the treatment of HSDD in women.

Mechanism of Action: Flibanserin exerts its effects by modulating serotonin receptors in the brain, particularly serotonin 5-HT1A and 5-HT2A receptors. It acts as a serotonin receptor agonist and antagonist, increasing the release of dopamine and norepinephrine while decreasing the release of serotonin in certain brain regions associated with sexual desire and arousal. This helps to restore the balance of neurotransmitters involved in sexual function, leading to an increase in sexual desire and arousal.

Benefits:

1. Increased Sexual Desire: Fliban 100 is effective in increasing sexual desire and arousal in premenopausal women with HSDD, leading to improvements in sexual satisfaction and quality of life.
2. Reduction of Distress: Treatment with Flibanserin can help reduce the distress and interpersonal difficulties associated with HSDD, allowing women to enjoy a more fulfilling sex life and healthier relationships.
3. Improved Relationship Dynamics: By addressing underlying issues of low sexual desire, Flibanserin may help improve communication and intimacy between partners, leading to stronger and more satisfying relationships.
4. Non-Hormonal Option: Flibanserin is a non-hormonal medication, making it a suitable option for women who cannot or prefer not to use hormone-based treatments for HSDD, such as estrogen therapy.
5. Well-Tolerated: Fliban 100 is generally well-tolerated, with side effects typically mild to moderate and transient. Common side effects may include dizziness, nausea, fatigue, and somnolence.

Fliban 100 (Flibanserin) is an important medication for the treatment of hypoactive sexual desire disorder (HSDD) in premenopausal women, offering significant benefits in terms of increasing sexual desire, reducing distress, and improving relationship dynamics. However, it may take several weeks to see the full effects of treatment, and women should be counseled on the potential risks and benefits of Flibanserin therapy. This description is for informational purposes only and does not constitute medical advice.